Aloe emodin has been shown to act on esophageal cancer cells activated by the Akt/ERK pathway in a dose-dependent manner, inhibiting Akt and ERK phosphorylation and significantly reducing the number of S-phase cells [36]. This evidence concerns the gene AKT1 and esophageal cancer.